to Advance Efforts
The NHLBI’s Investment
The Initiative complements the National Heart, Lung, and Blood Institute (NHLBI)’s investment in sickle cell disease research, which includes basic, clinical, translational, and implementation science research. The Cure Sickle Cell Initiative does not replace ongoing research efforts; rather, it complements them. The NHLBI continues to fund research conducted by investigators focusing on sickle cell disease, and this Initiative helps fill gaps that cannot be covered by traditional funding methods.